ARPANSA’s Australian Clinical Dosimetry Service (ACDS) has carried out audits on a new Elekta Unity MRI-Linac in Townsville, Queensland before the treatment of the first patient.
The national data sets show the dose variation as measured by the ACDS in audits to date excluding follow up audits.
The Level III audit is an end-to-end test of the radiotherapy treatment pathway.
The Clinical Advisory Group was assembled by the ACDS to provide technical support and advice to the ACDS.
The Level Ib audit offers a more accurate measurement of the Linac output than the Level I audit. ACDS staff visit the facility and perform on-site measurements using ACDS dosimetry equipment.
The ACDS staff and alumni.
Publications relevant to the ACDS
The Level II audit is a diagnostic test of the Treatment Planning System performance.
The Level I mail out audit is an independent measurement of linac output under reference conditions.
© Commonwealth of Australia